Asparkam 60 pcs Table

$2.64

Asparkam 60 pcs Table

5 in stock

Quantity:

Description

Composition
Active substance:
1 tablet contains: potassium asparaginata gemigidrat- asparaginate and 0.175 g 0.175 g magnesium tetragidrat- ;.
Excipients:
Potato starch – 0.135 g talc – 0.010 g Calcium stearate – 0.005 g
Description:
Tablets white ploskotsilindricheskoy circular shape, with a chamfered and Valium.
Product form:
Tablets.
10 tablets in blisters. 1, 2, 3, 4, 5 or 6, the contour of cellular packaging together with instructions for use placed in a cardboard box (pack).
For hospitals: the contour of cellular packages 700 with an appropriate amount of instructions for use are placed in a cardboard box.
Contraindications
Increased sensitivity to the drug, impaired metabolism of amino acids, hypotension, acute and chronic renal failure, hyperkalemia, gipermagniemiya, impaired atrioventricular conduction (AV block I-III st.), Oliguria, anuria, myasthenia gravis, acute metabolic acidosis, impaired metabolism of amino acids, dehydration (exsicosis), hemolysis, Addison’s disease.
Precautions: hypophosphatemia, urolithiasis diathesis (associated with metabolic impairment of Ca2 +, Mg2 +, and ammonium phosphate), pregnancy (especially I trimester) and lactation.
Dosage
175mg + 175mg
Indications
Shortfall of K + and Mg2 + (in the complex therapy), including coronary heart disease (including acute myocardial infarction), congestive heart failure, arrhythmias (including cardiac glycosides amid overdose).
Interaction with other drugs
Pharmacodynamic: combined use of potassium-sparing diuretics (triamterene, spironolactone), beta-blockers, cyclosporine, heparin, ACE inhibitors, nonsteroidal antiinflammatory drugs increases the risk of hyperkalemia until the development of arrhythmias and asystole. The use of drugs in conjunction with potassium glucocorticosteroids eliminates hypokalemia caused by the latter. Under the influence of potassium decreases the unwanted effects of cardiac glycosides. Magnesium reduces the effect of neomycin, polymyxin B, tetracycline and streptomycin. Anesthetics magnesium increase inhibitory effect of drugs on the central nervous system; while the use of atrakuroniem, decamethonium, succinyl and suxamethonium may increase neuromuscular blockade; calcitriol increases the magnesium content in blood plasma, calcium supplementation reduces the effect of magnesium preparations.
Enhances the negative effects batmotroponoe Drome and antiarrhythmics. Pharmacokinetic: knitting and enveloping means reduce the absorption of the drug in the gastrointestinal tract.
Overdose
Symptoms: hyperkalemia and gipermagniemiya.
Treatment: intravenous calcium chloride; if necessary – hemodialysis and peritoneal dialysis.
pharmachologic effect
Pharmacological group:
Potassium and magnesium preparation.
Pharmacodynamics:
Asparkam a source of potassium and magnesium ions, regulates metabolic processes. The mechanism of action presumably associated with potassium and magnesium asparaginata role as a carrier of magnesium and potassium ions in the intercellular space, and its involvement in metabolic processes. Thus Asparkam eliminates electrolyte imbalance, decreases myocardial excitability and conductivity (moderate antiarrhythmic effect).
Pharmacokinetics:
Easily absorbed when taken orally and relatively rapidly excreted by the kidneys.
Conditions of supply of pharmacies
On prescription.
side effects
Nausea, vomiting, diarrhea, epigastric pain (in patients with anatsidnyh gastritis or cholecystitis), hyperkalemia (nausea, vomiting, diarrhea, and paresthesia) and gipermagniemiya (facial flushing, thirst, bradycardia, decrease in blood pressure, muscle weakness, fatigue paresis, coma, areflexia, respiratory depression, convulsions).
special instructions
Requires regular monitoring of performance electrolyte homeostasis.
Storage conditions
At a temperature of not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Asparkam appointed interior, after a meal. Usually prescribed for adults 1-2 tablets 3 times a day. The course of treatment – 3-4 weeks. repeat the course if necessary.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

FARMAPOL

There are no reviews yet.

Add your review